VEZF1 and hepatocellular carcinoma: Importantly, we also found that OSMI-1 reduced the proliferation and migration capacity of VEZF1WT overexpressed cells, the opposite results were obtained with TMG treatment, (Fig. 6A, B and Fig. S6A, B), indicating the crucial role of VEZF1 O-GlcNAcylation in HCC progression.